CLOs on the Move

Olema Pharmaceuticals

www.olemapharma.com

 
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Graybug Vision

Every day, Graybug Vision works relentlessly to make healthy vision more accessible and more manageable for patients with chronic vision-threatening eye diseases. We are a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve. Our novel technologies are designed to release drugs in ocular tissue at a controlled rate for up to 12 months in order to improve patient compliance, reduce healthcare burdens and, ultimately, deliver better clinical outcomes.

Tapestry Pharmaceuticals

Tapestry Pharmaceuticals, Inc. is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ViroChem Pharma

ViroChem Pharma is a Laval, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Alnara Pharmaceuticals

Alnara Pharmaceuticals, Inc. is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Premier Research

Premier Research is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.